OptimizeRx CEO William Febbo gets $12.5M PRSU grant, base salary to $450k

OptimizeRx Corp

Base salary increased to $450,000 upon signing; annual target bonus raised to 100% of base salary.
Granted $12.5M performance-based RSUs with three stock price milestones: 50%, 100%, 150% above base price of $65.91.
PRSUs earned over five years; each milestone requires stock price >= target for 30 consecutive trading days; vesting on first anniversary of milestone date.
RSU grant intended as CEO's only equity award for next five years, replacing annual grants; compensation committee may reconsider.
Milestones set for compensation purposes only; not management projection.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.